[Contact: Linda Chien Investor Relations 51job, Inc. +86-21-6879-6250 ir@51job.com 51job, Inc. Reports Second Quarter 2018 Financial Results SHANGHAI, August 2, 2018 51job, Inc. (Nasdaq: JOBS) Second Quarter 2018 Financial Highlights: · Total revenues increased 33.0% over Q2 2017 to RMB895.5 million ]
[Contact: Linda Chien Investor Relations 51job, Inc. +86-21-6879-6250 ir@51job.com 51job, Inc. Reports Second Quarter 2018 Financial Results SHANGHAI, August 2, 2018 51job, Inc. (Nasdaq: JOBS) Second Quarter 2018 Financial Highlights: · Total revenues increased 33.0% over Q2 2017 to RMB895.5 million ]
[Hanwha Q CELLS Announces Formation of an Independent Special Committee Seoul, South Korea, August 3, 2018 -- Hanwha Q CELLS Co., Ltd. ("Hanwha Q CELLS" or the "Company") (NASDAQ: HQCL), a global leading photovoltaic manufacturer of high-performance, high-quality solar modules, today announced that t]
[Hanwha Q CELLS Announces Formation of an Independent Special Committee Seoul, South Korea, August 3, 2018 -- Hanwha Q CELLS Co., Ltd. ("Hanwha Q CELLS" or the "Company") (NASDAQ: HQCL), a global leading photovoltaic manufacturer of high-performance, high-quality solar modules, today announced that t]
[UTSTARCOM HOLDINGS CORP. No. Description 99.1 Press Release regarding UTStarcom Reports Unaudited Financial Results for the Second Quarter of 2018 1]
[UTSTARCOM HOLDINGS CORP. No. Description 99.1 Press Release regarding UTStarcom Reports Unaudited Financial Results for the Second Quarter of 2018 1]
[This Form 6-K consists of: Monthly Return of Equity Issuer on Movements in Securities For the month ended (dd/mm/yyyy) : 31/07/2018 To : Hong Kong Exchanges and Clearing Limited Name of Issuer Huaneng Power International, Inc Date Submitted 01/08/2018 I. Movements in Authorised Share Capital 1. Ordi]
[This Form 6-K consists of: Monthly Return of Equity Issuer on Movements in Securities For the month ended (dd/mm/yyyy) : 31/07/2018 To : Hong Kong Exchanges and Clearing Limited Name of Issuer Huaneng Power International, Inc Date Submitted 01/08/2018 I. Movements in Authorised Share Capital 1. Ordi]
[FOR RELEASE August 3, 2018 China Biologic Reports Financial Results for the Second Quarter of 2018 --2Q18 Total Sales Up 25.5% YoY and Non-GAAP Adjusted Net Income Down 2.8% YoY in RMB terms, or Total Sales Up 34.8% YoY to $120.4 Million and Net Income Down 7.7% YoY to $28.6 Million in USD terms— --]
[FOR RELEASE August 3, 2018 China Biologic Reports Financial Results for the Second Quarter of 2018 --2Q18 Total Sales Up 25.5% YoY and Non-GAAP Adjusted Net Income Down 2.8% YoY in RMB terms, or Total Sales Up 34.8% YoY to $120.4 Million and Net Income Down 7.7% YoY to $28.6 Million in USD terms— --]
